AS PER WHO

■ In 2015, World Health Organisation (WHO) recommended TB lipoarabinomannan (LAM) or TB LAM test for HIV patients who are critically ill and have low immunity

■ According to WHO, a urine-based test has advantages over other tests because urine is easy to collect, store, and lacks infection control risks associated with sputum collection.